WO2024068845 - NEW LOXPSYM SITES FOR LARGE-SCALE ORTHOGONAL CRE-MEDIATED RECOMBINATION
National phase entry:
Publication Number
WO/2024/068845
Publication Date
04.04.2024
International Application No.
PCT/EP2023/076902
International Filing Date
28.09.2023
Title **
[English]
NEW LOXPSYM SITES FOR LARGE-SCALE ORTHOGONAL CRE-MEDIATED RECOMBINATION
[French]
NOUVEAUX SITES LOXPSYM POUR RECOMBINAISON INDUITE PAR CRE ORTHOGONALE À GRANDE ÉCHELLE
Applicants **
VIB VZW
KATHOLIEKE UNIVERSITEIT LEUVEN
Inventors
VERSTREPEN, Kevin
CAUTEREELS, Charlotte
Priority Data
22198794.4
29.09.2022
EP
23190947.4
10.08.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2832 | |
| EPO | Filing, Examination, Granting | 17881 | |
| Japan | Filing, Examination, Granting | 2678 | |
| South Korea | Filing, Examination, Granting | 3164 | |
| USA | Filing, Examination, Granting | 11940 |
Total:
38,495
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to the field of genetic engineering and synthetic biology, more particularly to means and methods for facilitating genetic recombination. The application discloses novel Cre recombinase dependent recombination sites that supports a simultaneous cloning and testing approach.[French]
L'invention concerne le domaine de l'ingénierie génétique et de la biologie synthétique, plus particulièrement des moyens et des procédés pour faciliter la recombinaison génétique. L'invention concerne de nouveaux sites de recombinaison dépendant de la recombinase Cre qui prennent en charge une approche de clonage et de test simultanée.